Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sirius XM Holdings Inc (SIRI) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Sirius XM Holdings IncTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Sirius XM Holdings Inc vs Health Care Select Sector SPDR Fund — how do they compare? Sirius XM Holdings Inc trades at $26.51 (market cap $8.87B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 4.9× Sirius XM Holdings Inc's market cap, and Sirius XM Holdings Inc pays a 4.1% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sirius XM Holdings Inc for 102 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

SIRIXLV
Market Cap
$8.87B$43.48B
Volume
4,324,67211,121,431
Sector
Media—
52-Week High
$32.59$175.68
52-Week Low
$19.92$141.95
Typical Hold Time
102 Days100 Days
Enterprise Value
$18.16B—
Dividend Yield
4.1%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sirius XM Holdings Inc

Sirius XM Holdings (SIRI) trades at $26.33, up 1.46% on the day, with a neutral technical signal and mixed earnings history. The stock shows attractive valuation metrics with a P/E of 10.57 and P/B of 0.75, while profitability remains solid with a 10.23% net margin. Recent news highlights the company's YouTube partnership potential and strong cash flow growth, with institutional buying activity noted in September 2026.

The outlook is cautiously optimistic with a consensus price target of $34.43 suggesting 31% upside, though risks include competitive pressures in audio streaming and execution on new initiatives. The company's debt reduction and stable cash generation support the bullish analyst sentiment, but investors should weigh the recent earnings misses against growth initiatives.

Health Care Select Sector SPDR Fund

XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.

XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SIRI
100% Buy0% Sell
Avg holding period · 102 Days
XLV
44% Buy56% Sell
Avg holding period · 100 Days

Top news

Latest headlines on both assets

About Sirius XM Holdings Inc

SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.

Read more on SIRI →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →